López-Machado, A.; DÃaz-Garrido, N.; Cano, A.; Espina, M.; Badia, J.; Baldomà , L.; Calpena, A.C.; Souto, E.B.; GarcÃa, M.L.; Sánchez-López, E.
Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation. Pharmaceutics 2021, 13, 1698.
https://doi.org/10.3390/pharmaceutics13101698
AMA Style
López-Machado A, DÃaz-Garrido N, Cano A, Espina M, Badia J, Baldomà L, Calpena AC, Souto EB, GarcÃa ML, Sánchez-López E.
Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation. Pharmaceutics. 2021; 13(10):1698.
https://doi.org/10.3390/pharmaceutics13101698
Chicago/Turabian Style
López-Machado, Ana, Natalia DÃaz-Garrido, Amanda Cano, Marta Espina, Josefa Badia, Laura Baldomà , Ana Cristina Calpena, Eliana B. Souto, MarÃa Luisa GarcÃa, and Elena Sánchez-López.
2021. "Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation" Pharmaceutics 13, no. 10: 1698.
https://doi.org/10.3390/pharmaceutics13101698
APA Style
López-Machado, A., DÃaz-Garrido, N., Cano, A., Espina, M., Badia, J., Baldomà , L., Calpena, A. C., Souto, E. B., GarcÃa, M. L., & Sánchez-López, E.
(2021). Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation. Pharmaceutics, 13(10), 1698.
https://doi.org/10.3390/pharmaceutics13101698